Absence of somatic sdhd mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients

Absence of somatic sdhd mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients

Play all audios:

Loading...

ABSTRACT Allelic loss of the long arm of chromosome 11 is frequent in neuroendocrine tumors (NET) of different organs. However, the _MEN1_ gene on 11q13 is mutated only in a subset of NET


and allelic losses on 11q frequently extend to the telomere. In this genetic region lies the tumor suppressor gene _SDHD_ which is associated with hereditary paragangliomas (_PGL1_). We


sought to determine whether _SDHD_ plays a role in the development of sporadic NET. By mutation and deletion analysis of _SDHD_ we were unable to detect any _SDHD_ mutation in 45 NET of the


lung, gastrointestinal tract, pancreas or parathyroid. However, we found allelic deletions in 20 to 50% of all tumors but parathyroid adenomas. Furthermore, we found heterozygous germline


variants in 2/8 paragangliomas. A first case of variant c.149 A>G (H50R) was found in a patient with an extra-adrenal pheochromocytoma, the other variant c.34 G>A (G12S) in a patient


with a paratracheal paraganglioma, C-cell hyperplasia of the thyroid and hyperplasia of ACTH-producing cells of the pituitary gland. Both variants were absent in 93 controls. Our results


demonstrate that somatic _SDHD_ mutations are rare in sporadic NET. However, LOH alone could lead to a complete loss of function since _SDHD_ is an imprinted gene. Furthermore, we describe


two germline variants possibly causing hereditary paragangliomas. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution


ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 50 print issues and online access $259.00 per year only $5.18 per issue Learn more Buy this article *


Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn


about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS _GIPC2_ IS AN ENDOCRINE-SPECIFIC TUMOR SUPPRESSOR GENE FOR BOTH SPORADIC


AND HEREDITARY TUMORS OF RET- AND SDHB-, BUT NOT VHL-ASSOCIATED CLUSTERS OF PHEOCHROMOCYTOMA/PARAGANGLIOMA Article Open access 04 May 2021 NOVEL SOMATIC VARIANTS INVOLVED IN BIOCHEMICAL


ACTIVITY OF PURE GROWTH HORMONE-SECRETING PITUITARY ADENOMA WITHOUT _GNAS_ VARIANT Article Open access 16 August 2021 VHL MOSAICISM: THE ADDED VALUE OF MULTI-TISSUE ANALYSIS Article Open


access 18 March 2022 REFERENCES * Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR . 2001 _Genes Chromosomes Cancer_ 31: 255–263 * Baysal BE, Ferrell RE, Willett-Brozick


JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P, Devlin B . 2000 _Science_ 287: 848–851 * Baysal BE, van


Schothorst EM, Farr JE, Grashof P, Myssiorek D, Rubinstein WS, Taschner P, Cornelisse CJ, Devlin B, Devilee P, Richard 3rd CW . 1999 _Hum. Genet._ 104: 219–225 * Chakrabarti R, Srivatsan


ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro EJ, Sawicki MP . 1998 _Genes Chromosomes Cancer_ 22: 130–137 * D'Adda T, Keller G, Bordi C, Hofler H . 1999 _Lab. Invest._ 79:


671–677 * Dannenberg H, Speel EJ, Zhao J, Saremaslani P, van Der Harst E, Roth J, Heitz PU, Bonjer HJ, Dinjens WN, Mooi WJ, Komminoth P, de Krijger RR . 2000 _Am. J. Pathol._ 157: 353–359 *


Eubanks PJ, Sawicki MP, Samara GJ, Gatti R, Nakamura Y, Tsao D, Johnson C, Hurwitz M, Wan Y-JY, Passaro E . 1994 _Am. J. Surg._ 167: 180–185 * Farnebo F, Kytola S, Teh BT, Dwight T, Wong FK,


Hoog A, Elvius M, Wassif WS, Thompson NW, Farnebo LO, Sandelin K, Larsson C . 1999 _J. Clin. Endocrinol. Metab._ 84: 3775–3780 * Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A,


White I, Betz R, Goretzki P, Sandelin K, Farnebo LO, Larsson C . 1997 _Hum. Genet._ 99: 342–349 * Friedman E, De Marco L, Gejman PV, Norton JA, Bale AE, Aurbach GD, Spiegel AM, Marx SJ .


1992 _Cancer Res._ 52: 6804–6809 * Gimm O, Armanios M, Dziema H, Neumann HP, Eng C . 2000 _Cancer Res._ 60: 6822–6825 * Gortz B, Roth J, Krahenmann A, de Krijger RR, Muletta-Feurer S,


Rutimann K, Saremaslani P, Speel EJ, Heitz PU, Komminoth P . 1999 _Am. J. Pathol._ 154: 429–436 * Hagerhall C . 1997 _Biochim. Biophys. Acta._ 1320: 107–141 * Hirawake H, Taniwaki M, Tamura


A, Amino H, Tomitsuka E, Kita K . 1999 _Biochim. Biophys Acta_ 1412: 295–300 * Iwasaki H . 1996 _Int. Surg._ 81: 71–76 * Jakobovitz G, Nass D, Demarco L, Barbosa A, Simoni FB, Rechavi G,


Friedman E . 1996 _J. Clin. Endocrinol. Metab._ 81: 3164–3167 * Koehler CM . 2000 _FEBS Lett._ 476: 27–31 * Komminoth P, Kunz E, Hiort O, Schroder S, Matias-Guiu X, Christiansen G, Roth J,


Heitz PU . 1994 _Am. J. Pathol._ 145: 922–929 * Malik K, Salpekar A, Hancock A, Moorwood K, Jackson S, Charles A, Brown KW . 2000 _Cancer Res._ 60: 2356–2360 * Perren A, Roth J,


Muletta-Feurer S, Saremaslani P, Speel EJ, Heitz PU, Komminoth P . 1998 _J. Pathol._ 186: 363–371 * Petzmann S, Ullmann R, Klemen H, Renner H, Popper HH . 2001 _Hum. Pathol._ 32: 333–338 *


Pfanner N . 2000 _Curr. Biol._ 10: R412–R415 * Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, Pesci A, Baron A, Lissandrini D, Rindi G, Grigolato P, Pederzoli P, Scarpa


A . 2001 _Cancer Res._ 61: 285–292 * Scheffler IE . 1998 _Prog. Nucleic Acids. Res. Mol. Biol._ 60: 267–315 * Speel EJ, Richter J, Moch H, Egenter C, Saremaslani P, Rutimann K, Zhao J,


Barghorn A, Roth J, Heitz PU, Komminoth P . 1999 _Am. J. Pathol._ 155: 1787–1794 * van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ . 1989 _Lancet_ 2: 1291–1294


* Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Prauer HW, Werner M, Hofler H . 1998 _Am. J. Pathol._ 153: 1089–1098 * Zhao J, de Krijger RR, Meier D, Speel EJ,


Saremaslani P, Muletta-Feurer S, Matter C, Roth J, Heitz PU, Komminoth P . 2000 _Am. J. Pathol._ 157: 1431–1438 Download references ACKNOWLEDGEMENTS Supported by Swiss Cancer League grant


SKL-997-02-2000 and Swiss National Science Foundation grant 31-618845.00. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Pathology, University Hospital, Zurich, 8091,


Switzerland Aurel Perren, André Barghorn, Sonja Schmid, Parvin Saremaslani, Jürgen Roth & Philipp U Heitz * Institue of Pathology, Baden, 5404, Switzerland Paul Komminoth Authors * Aurel


Perren View author publications You can also search for this author inPubMed Google Scholar * André Barghorn View author publications You can also search for this author inPubMed Google


Scholar * Sonja Schmid View author publications You can also search for this author inPubMed Google Scholar * Parvin Saremaslani View author publications You can also search for this author


inPubMed Google Scholar * Jürgen Roth View author publications You can also search for this author inPubMed Google Scholar * Philipp U Heitz View author publications You can also search for


this author inPubMed Google Scholar * Paul Komminoth View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Aurel Perren.


RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Perren, A., Barghorn, A., Schmid, S. _et al._ Absence of somatic _SDHD_ mutations in sporadic


neuroendocrine tumors and detection of two germline variants in paraganglioma patients. _Oncogene_ 21, 7605–7608 (2002). https://doi.org/10.1038/sj.onc.1205812 Download citation * Received:


03 April 2002 * Revised: 28 June 2002 * Accepted: 28 June 2002 * Published: 18 October 2002 * Issue Date: 24 October 2002 * DOI: https://doi.org/10.1038/sj.onc.1205812 SHARE THIS ARTICLE


Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided


by the Springer Nature SharedIt content-sharing initiative KEYWORDS * _SDHD_ * endocrine tumors * mutation * allelic loss